SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-23-010412
Filing Date
2023-03-31
Accepted
2023-03-31 17:17:26
Documents
23
Period of Report
2023-02-14
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 197964
2 ex10-83.htm EX-10.83 5750
3 ex99-2.htm EX-99.2 260749
4 ex99-3.htm EX-99.3 232585
5 ex99-4.htm EX-99.4 309927
6 ex10-83_001.jpg GRAPHIC 490760
7 ex10-83_002.jpg GRAPHIC 363593
8 ex10-83_003.jpg GRAPHIC 427732
9 ex10-83_004.jpg GRAPHIC 351965
10 ex10-83_005.jpg GRAPHIC 70649
11 ex10-83_006.jpg GRAPHIC 86586
  Complete submission text file 0001493152-23-010412.txt   3843756

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE aeha-20230214.xsd EX-101.SCH 4088
13 XBRL DEFINITION FILE aeha-20230214_def.xml EX-101.DEF 28390
14 XBRL LABEL FILE aeha-20230214_lab.xml EX-101.LAB 38048
15 XBRL PRESENTATION FILE aeha-20230214_pre.xml EX-101.PRE 26602
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 7873
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40793 | Film No.: 23789189
SIC: 2834 Pharmaceutical Preparations